entecavir

FDA Drug Profile — BARACLUDE, ENTECAVIR, Entecavir

entecavir is listed in the FDA National Drug Code directory with 13 NDC codes, marketed under brand names including BARACLUDE, ENTECAVIR, Entecavir. Available dosage forms: tablet, film coated, solution.

Drug details

Generic Name
entecavir
Brand Names
BARACLUDE, ENTECAVIR, Entecavir
Application Number
NDA021797
Sponsor
E.R. Squibb & Sons, L.L.C.
NDC Codes
13
Dosage Forms
TABLET, FILM COATED, SOLUTION
Routes
ORAL
Active Ingredients
ENTECAVIR, ENTECAVIR ANHYDROUS

Indications and Usage

1 INDICATIONS AND USAGE Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease Entecavir is a hepatitis B virus nucleoside analogue reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis B virus infection in adults and children at least 2 years of age with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. (1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.